Su Wang
Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Clinical Trials as Topic | 2 | 2009 | 251 |
Why?
|
Stem Cells | 6 | 1997 | 107 |
Why?
|
Telomerase | 2 | 2007 | 15 |
Why?
|
Flow Cytometry | 6 | 1998 | 216 |
Why?
|
Neurons | 7 | 1996 | 195 |
Why?
|
SOXB1 Transcription Factors | 1 | 2010 | 5 |
Why?
|
Neural Stem Cells | 1 | 2010 | 8 |
Why?
|
Central Nervous System Agents | 1 | 2010 | 5 |
Why?
|
Enhancer Elements, Genetic | 2 | 2000 | 43 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 14 |
Why?
|
Central Nervous System Diseases | 1 | 2010 | 33 |
Why?
|
Promoter Regions, Genetic | 6 | 1996 | 188 |
Why?
|
Patient Selection | 1 | 2009 | 155 |
Why?
|
Computer Simulation | 1 | 2009 | 134 |
Why?
|
Models, Statistical | 1 | 2009 | 114 |
Why?
|
Tubulin | 4 | 1998 | 26 |
Why?
|
Cerebral Ventricles | 2 | 2000 | 32 |
Why?
|
Luminescent Proteins | 5 | 1998 | 67 |
Why?
|
Cell Separation | 5 | 1998 | 110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2006 | 135 |
Why?
|
Gene Expression Profiling | 4 | 2006 | 138 |
Why?
|
Sample Size | 2 | 2009 | 24 |
Why?
|
Ependyma | 1 | 2000 | 7 |
Why?
|
Mitosis | 1 | 2000 | 68 |
Why?
|
Oxazines | 2 | 2006 | 16 |
Why?
|
Pyridines | 2 | 2006 | 61 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2006 | 77 |
Why?
|
Prosencephalon | 3 | 1998 | 29 |
Why?
|
Inflammation | 2 | 2006 | 208 |
Why?
|
Green Fluorescent Proteins | 5 | 1998 | 105 |
Why?
|
Cells, Cultured | 5 | 1998 | 447 |
Why?
|
Fetus | 2 | 2002 | 105 |
Why?
|
Brain | 2 | 1997 | 305 |
Why?
|
Liver Diseases | 1 | 2010 | 56 |
Why?
|
Cell Lineage | 1 | 2010 | 60 |
Why?
|
Equipment Failure Analysis | 2 | 2006 | 44 |
Why?
|
Humans | 12 | 1997 | 1856 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2009 | 31 |
Why?
|
Corpus Callosum | 1 | 2008 | 10 |
Why?
|
Research Design | 1 | 2010 | 169 |
Why?
|
Lung Diseases | 1 | 2010 | 112 |
Why?
|
Adult Stem Cells | 1 | 2008 | 16 |
Why?
|
Logistic Models | 1 | 2010 | 251 |
Why?
|
Myelin Sheath | 1 | 2008 | 30 |
Why?
|
Prodrugs | 1 | 2007 | 16 |
Why?
|
Rats | 5 | 1996 | 530 |
Why?
|
Fetal Stem Cells | 1 | 2007 | 3 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 50 |
Why?
|
Cytoplasm | 1 | 2007 | 108 |
Why?
|
Neuroglia | 1 | 2008 | 49 |
Why?
|
Nerve Tissue Proteins | 2 | 2000 | 128 |
Why?
|
Retroviridae | 1 | 2007 | 36 |
Why?
|
Transfection | 5 | 1998 | 237 |
Why?
|
Antigen-Antibody Complex | 1 | 2006 | 34 |
Why?
|
Receptors, Fc | 1 | 2006 | 28 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 74 |
Why?
|
Animals | 9 | 1996 | 1031 |
Why?
|
Arthritis, Rheumatoid | 1 | 2007 | 53 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2007 | 73 |
Why?
|
Breast Neoplasms | 2 | 2009 | 185 |
Why?
|
Prospective Studies | 1 | 2010 | 545 |
Why?
|
Cerebral Cortex | 1 | 2007 | 108 |
Why?
|
Bone Resorption | 1 | 2007 | 49 |
Why?
|
Spleen | 1 | 2006 | 129 |
Why?
|
Quality Assurance, Health Care | 1 | 2006 | 83 |
Why?
|
Astrocytes | 1 | 2007 | 62 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 241 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 216 |
Why?
|
Transcription, Genetic | 2 | 1996 | 253 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 190 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2002 | 6 |
Why?
|
SUMO-1 Protein | 1 | 2002 | 12 |
Why?
|
Neoplasms | 1 | 2010 | 239 |
Why?
|
Amyloid beta-Peptides | 1 | 2002 | 24 |
Why?
|
Treatment Outcome | 1 | 2010 | 661 |
Why?
|
RNA | 1 | 2006 | 126 |
Why?
|
Signal Transduction | 3 | 1996 | 313 |
Why?
|
Rats, Sprague-Dawley | 2 | 2000 | 257 |
Why?
|
Recombinant Fusion Proteins | 2 | 1996 | 189 |
Why?
|
2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 1999 | 3 |
Why?
|
Dentate Gyrus | 1 | 2000 | 20 |
Why?
|
Gene Targeting | 1 | 2000 | 51 |
Why?
|
Hippocampus | 1 | 2000 | 83 |
Why?
|
Quality Control | 2 | 2006 | 54 |
Why?
|
Cell Division | 2 | 1997 | 273 |
Why?
|
Oligodendroglia | 1 | 1999 | 25 |
Why?
|
Chick Embryo | 1 | 1998 | 62 |
Why?
|
Mammals | 1 | 1997 | 47 |
Why?
|
Arthus Reaction | 2 | 2006 | 1 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 9 |
Why?
|
Female | 3 | 2007 | 1643 |
Why?
|
Endothelial Growth Factors | 1 | 1996 | 47 |
Why?
|
Lymphokines | 1 | 1996 | 61 |
Why?
|
Nerve Growth Factors | 1 | 1996 | 43 |
Why?
|
Biological Markers | 1 | 1998 | 262 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1998 | 119 |
Why?
|
Disease Models, Animal | 2 | 2007 | 349 |
Why?
|
Immunoglobulin G | 2 | 2006 | 191 |
Why?
|
Age Factors | 1 | 1997 | 480 |
Why?
|
Reproducibility of Results | 2 | 2006 | 391 |
Why?
|
Sensitivity and Specificity | 2 | 2006 | 427 |
Why?
|
Adult | 4 | 1997 | 1317 |
Why?
|
Mice | 3 | 2006 | 623 |
Why?
|
Gene Expression Regulation | 1 | 1996 | 277 |
Why?
|
Transcription Factors | 1 | 1996 | 201 |
Why?
|
Intermediate Filament Proteins | 2 | 2000 | 17 |
Why?
|
Neuroblastoma | 1 | 2010 | 36 |
Why?
|
Multiple Myeloma | 1 | 2010 | 44 |
Why?
|
Guidelines as Topic | 1 | 2010 | 77 |
Why?
|
Agenesis of Corpus Callosum | 1 | 2008 | 5 |
Why?
|
Transplantation Chimera | 1 | 2008 | 22 |
Why?
|
Ranvier's Nodes | 1 | 2008 | 9 |
Why?
|
Tissue Therapy | 1 | 2008 | 5 |
Why?
|
United States | 2 | 2006 | 604 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 321 |
Why?
|
Survival Analysis | 1 | 2010 | 205 |
Why?
|
Tissue Distribution | 1 | 2008 | 124 |
Why?
|
Immunocompromised Host | 1 | 2008 | 70 |
Why?
|
Synovial Fluid | 1 | 2007 | 12 |
Why?
|
Neural Conduction | 1 | 2008 | 41 |
Why?
|
Demyelinating Diseases | 1 | 2008 | 28 |
Why?
|
Synovitis | 1 | 2007 | 14 |
Why?
|
Collagen Type II | 1 | 2007 | 14 |
Why?
|
Genes, Reporter | 2 | 1996 | 111 |
Why?
|
Puromycin | 1 | 2007 | 10 |
Why?
|
Receptors, IgG | 1 | 2007 | 30 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 2006 | 3 |
Why?
|
Crystallography | 1 | 2006 | 11 |
Why?
|
Stimulation, Chemical | 1 | 2006 | 42 |
Why?
|
Karyotyping | 1 | 2007 | 47 |
Why?
|
Telomere | 1 | 2007 | 10 |
Why?
|
Basophils | 1 | 2006 | 13 |
Why?
|
Mast Cells | 1 | 2006 | 31 |
Why?
|
Platelet Aggregation | 1 | 2006 | 33 |
Why?
|
Arthritis, Experimental | 1 | 2006 | 15 |
Why?
|
Culture Media | 1 | 2007 | 116 |
Why?
|
Animals, Newborn | 1 | 2008 | 175 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2006 | 83 |
Why?
|
Spinal Cord | 1 | 2007 | 94 |
Why?
|
Equipment Design | 1 | 2006 | 132 |
Why?
|
Lipopolysaccharides | 1 | 2006 | 98 |
Why?
|
Reference Values | 1 | 2006 | 278 |
Why?
|
Mice, Transgenic | 1 | 2007 | 209 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 176 |
Why?
|
Blotting, Western | 1 | 2006 | 275 |
Why?
|
Macrophages | 1 | 2006 | 148 |
Why?
|
Double-Blind Method | 1 | 2006 | 274 |
Why?
|
Ubiquitins | 1 | 2002 | 14 |
Why?
|
Algorithms | 1 | 2006 | 226 |
Why?
|
Ubiquitin | 1 | 2002 | 41 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 318 |
Why?
|
B-Lymphocytes | 1 | 2006 | 134 |
Why?
|
Protein Processing, Post-Translational | 1 | 2002 | 78 |
Why?
|
Plasmids | 1 | 2002 | 122 |
Why?
|
Genetic Vectors | 1 | 2002 | 139 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 233 |
Why?
|
Kinetics | 1 | 2002 | 349 |
Why?
|
Kidney | 1 | 2002 | 223 |
Why?
|
Cell Line | 1 | 2002 | 375 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1996 | 39 |
Why?
|
Recombinant Proteins | 1 | 1999 | 290 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 1996 | 11 |
Why?
|
PC12 Cells | 1 | 1996 | 27 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1996 | 43 |
Why?
|
Globins | 1 | 1996 | 21 |
Why?
|
Genes | 1 | 1996 | 82 |
Why?
|
Cyclic AMP | 1 | 1996 | 89 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 1996 | 94 |
Why?
|
Transcriptional Activation | 1 | 1996 | 99 |
Why?
|
Neoplasm Proteins | 1 | 1996 | 110 |
Why?
|
Child, Preschool | 1 | 2000 | 554 |
Why?
|
Base Sequence | 1 | 1996 | 371 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 404 |
Why?
|
Male | 1 | 2000 | 1553 |
Why?
|
